Previous Page  3 / 19 Next Page
Information
Show Menu
Previous Page 3 / 19 Next Page
Page Background

Page 18

allied

academies

Current Pediatric Research| Volume: 22

November 28-29, 2018 | Dubai, UAE

15

th

World Congress on

Pediatrics, Clinical Pediatrics and Nutrition

28

th

International Conference on

Nursing Practice

Joint Event

&

Nurses’ use of a defined competencies framework to support adults with Epilepsy and intellectual

disability-Findings from the EpAID study

Fiona Irvine

University of Birmingham, UK

T

he World Health Organisation defines intellectual disability

(ID) as “a significantly reduced ability to understand new

or complex information and to learn and apply new skills

(impaired intelligence). This results in a reduced ability to cope

independently (impaired social functioning), and begins before

adulthood, with a lasting effect on development”. Epilepsy is

themost commonmedical illness in people with IDs. Compared

to the general population with epilepsy, individuals with an

ID and epilepsy have an increased seizure frequency, higher

frequencies of multiple antiepileptic drug use and side effects,

higher treatment costs, higher rates of mortality and a greater

incidence of behavioural problems.

In the UK, Epilepsy Specialist Nurses (ESNs) with enhanced

expertise in the management of epilepsy, offer a range of

services to patients with epilepsy, including patient assessment,

medication management, ordering and interpreting

investigations and providing education, support and counselling

to patients and families. However, most people with ID and

epilepsy do not receive services from an ESN even though

anecdotal evidence suggests that ESNs may help to improve

outcomes and reduce the costs of care for adults with epilepsy

and an ID.

The Royal College of Nursing has developed a series of

competency frameworks for nurses, including the Learning

Disability Epilepsy Specialist Nurse Competency Framework,

that aims to improve outcomes for adults with an ID and

epilepsy. We set out to establish whether the development of

a nurse-led approach to managing epilepsy in adults with an

intellectual disability, basedon this RCNcompetency framework

improved outcomes and lowered costs of care for people with

epilepsy and ID.

We undertook a cluster randomised controlled trial to assess

the impact on costs and outcomes of the provision of learning

disability nurses working to the RCN competency framework.

The trial took place in 17 community ID clinical teams across

England, Scotland andWales and involved 312 adults with an ID

and epilepsy (the participants). Eight sites randomly allocated to

the intervention arm recruited 184 participants and nine sites

allocated to treatment as usual recruited 128 participants. After

completing baseline assessment of participants, we trained the

nurses in the intervention arm on the use of the competency

framework and they subsequently workedwith the participants

following the guidance outlined in the competency framework.

Nurses in the control arm, received minimal training and then

followed their existing management approach for participants.

All nurses in the study completed a daily diary in which they

recordedtheactivitiesthattheyundertookwiththeparticipants.

The trial intervention (or control) lasted aminimumof 24weeks

after which time; we followed up participants for a 4-week

period, when they completed a range of questionnaires and a

qualitative interview. We undertook an economic evaluation in

tandemwith the study.

Overall, the results of the trial indicated that, in terms of

clinical outcomes, the competency framework was no better

than treatment as usual. For those with a mild or moderate ID

the results suggested that use of the framework might have

been associated with a slight reduction in the severity of their

seizures, as noticed by somebody providing care for them. The

economic analysis suggested that, in general, the competency

framework intervention resulted in a small reduction in quality

of life but saved money.

The EpAID clinical trial is the first controlled trial to test the

possible benefits of a nurse-led intervention for epilepsy in

adults with an ID. It suggests that nurses with experience in

ID and epilepsy could be well placed to deliver or facilitate the

epilepsy management recommended for adults with an ID by

the relevant clinical guidelines.

Speaker Biography

Fiona Irvine qualified as a Registered Nurse from the Hammersmith Hospital School

of Nursing in 1984 and went on to work in Mid Wales as a District Nursing Sister and

latterly, a Macmillan Clinical Nurse Specialist in Palliative Care. During this time,

Fiona discovered her love of teaching and having completed her Master of Science

Degree in Health Promotion and Health Education, she took up her first academic post,

leading a specialist practice community nursing programme in North Wales. Whilst

working as a lecturer, following on from this work, Fiona became involved in several

funded research studies, which led to her securing her first professorial appointment

in 2007. Fiona held senior posts in universities in North Wales and the North West

of England before joining the University of Birmingham in March 2014 as Head of

Nursing. Since taking up the post, Fiona has been leading the reorganisation of nursing

and its relocation to the main building of the College of Medical and Dental Sciences.

e:

f.e.irvine@bham.ac.uk

Fiona Irvine, Pediatrics and Clinical Pediatrics 2018

& Nursing Practice 2018, Volume 22

DOI: 10.4066/0971-9032-C2-005